Literature DB >> 15099273

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women.

C J M Doggen1, R N Lemaitre, N L Smith, S R Heckbert, B M Psaty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15099273     DOI： 10.1111/j.1538-7836.2004.00696.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  17 in total

Review 1.  Statins, inflammation and deep vein thrombosis: a systematic review.

Authors:  April L Rodriguez; Brandon M Wojcik; Shirley K Wrobleski; Daniel D Myers; Thomas W Wakefield; Jose A Diaz
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

4.  Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.

Authors:  Ayelet Shai; Hedy S Rennert; Ofer Lavie; Muona Ballan-Haj; Arie Bitterman; Mariana Steiner; Shoshana Keren; Gad Rennert
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

Review 5.  Statins as a preventative therapy for venous thromboembolism.

Authors:  Alex Wallace; Hassan Albadawi; Peter Hoang; Andrew Fleck; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

6.  The effect and molecular mechanism of statins on the expression of human anti-coagulation genes.

Authors:  Sheng-Nan Chang; Cho-Kai Wu; Ling-Ping Lai; Fu-Tien Chiang; Juey-Jen Hwang; Chia-Ti Tsai
Journal:  Cell Mol Life Sci       Date:  2019-05-03       Impact factor: 9.261

7.  Preadmission statin use and one-year mortality among patients in intensive care - a cohort study.

Authors:  Steffen Christensen; Reimar W Thomsen; Martin B Johansen; Lars Pedersen; Reinhold Jensen; Kim M Larsen; Anders Larsson; Else Tønnesen; Henrik Toft Sørensen
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

8.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

Authors:  Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

9.  The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use.

Authors:  Laura B Harrington; Kerri L Wiggins; Colleen M Sitlani; Marc Blondon; Astrid van Hylckama Vlieg; Frits R Rosendaal; Susan R Heckbert; Bruce M Psaty; Nicholas L Smith
Journal:  Thromb Haemost       Date:  2015-12-03       Impact factor: 5.249

10.  Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.

Authors:  Kazem Rahimi; Neeraj Bhala; Pieter Kamphuisen; Jonathan Emberson; Sara Biere-Rafi; Vera Krane; Michele Robertson; John Wikstrand; John McMurray
Journal:  PLoS Med       Date:  2012-09-18       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.